Literature DB >> 24085760

Sarcoidosis induced by tocilizumab: a paradoxical event?

Anaiz Nutz1, Charlotte Pernet, Bernard Combe, Jean-David Cohen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24085760     DOI： 10.3899/jrheum.130278

Source DB:  PubMed          Journal:  J Rheumatol        ISSN： 0315-162X            Impact factor:   4.666


× No keyword cloud information.
  7 in total

Review 1.  The continuing evolution of targeted therapy for inflammatory skin disease.

Authors:  C Schlapbach; A A Navarini
Journal:  Semin Immunopathol       Date:  2015-09-30       Impact factor: 9.623

Review 2.  The Evolving Landscape of Cutaneous Sarcoidosis: Pathogenic Insight, Clinical Challenges, and New Frontiers in Therapy.

Authors:  Julie H Wu; Sotonye Imadojemu; Avrom S Caplan
Journal:  Am J Clin Dermatol       Date:  2022-05-18       Impact factor: 6.233

3.  Tocilizumab in sarcoidosis patients failing steroid sparing therapies and anti-TNF agents.

Authors:  Michelle Sharp; Seamas C Donnelly; David R Moller
Journal:  Respir Med X       Date:  2019-02-21

4.  New-onset cutaneous sarcoidosis under tocilizumab treatment for giant cell arteritis: a quasi-paradoxical adverse drug reaction. Case report and literature review.

Authors:  Rosaria Del Giorno; Alfonso Iodice; Cristina Mangas; Luca Gabutti
Journal:  Ther Adv Musculoskelet Dis       Date:  2019-04-12       Impact factor: 5.346

Review 5.  Refractory Sarcoidosis: A Review.

Authors:  Thomas El Jammal; Yvan Jamilloux; Mathieu Gerfaud-Valentin; Dominique Valeyre; Pascal Sève
Journal:  Ther Clin Risk Manag       Date:  2020-04-17       Impact factor: 2.423

Review 6.  Emerging Molecular Targets for the Treatment of Refractory Sarcoidosis.

Authors:  Gonçalo Boleto; Matheus Vieira; Anne Claire Desbois; David Saadoun; Patrice Cacoub
Journal:  Front Med (Lausanne)       Date:  2020-11-24

Review 7.  Tocilizumab in the treatment of rheumatoid arthritis and beyond.

Authors:  Anjali Shetty; Rebekah Hanson; Peter Korsten; Munir Shawagfeh; Shiva Arami; Suncica Volkov; Olga Vila; William Swedler; Abdel Naser Shunaigat; Sameer Smadi; Ray Sawaqed; David Perkins; Shiva Shahrara; Nadera J Sweiss
Journal:  Drug Des Devel Ther       Date:  2014-03-28       Impact factor: 4.162
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.